Europe is struggling more and more with extreme heat in the summer. While climate change is the main reason for this increase, what specific physical mechanisms cause a heat wave? One important driver ...

Pulsar Fusion is a UK-based space propulsion company developing advanced electric and fusion propulsion technologies for the rapidly growing satellite and deep-space markets. Pulsar’s systems are ...

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company, providing annealing and gate-model systems, software ...

314% increase in usage of D-Wave Advantage2 systems in last year reflects growing demand for annealing quantum computing Accelerated gate-model roadmap targets initial gate-model system availability ...

After a highly celebrated North American relaunch in 2024, Westfalia has been focused on expanding out its lineup one model at a time. On the very first day of this year's Florida RV Supershow, it ...

In the early days of D-Wave’s history, the company made a decision to pursue annealing as its first technology to build a quantum computer because it promised to offer the fastest path to commercial ...

D-Wave Quantum ( (QBTS)) has issued an update. On January 6, 2026, D-Wave Quantum Inc. announced it had achieved an industry-first breakthrough in gate-model quantum computing by successfully ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Washington Examiner columnist Joe Concha said Wednesday that the Democratic Party would be “wise” not to use its 2025 election strategy in the 2026 midterm elections, as it could alienate key voting ...

ABSTRACT: The underwater concrete structures are one of infrastructure facilities to secure the underwater environment safely, in which, the dam, the offshore platform, and under water bridge element ...

After becoming the first group to therapeutically edit human RNA in October 2024, Wave Life Sciences has released more data from its ongoing alpha-1 antitrypsin deficiency (AATD) clinical trial—and ...